Tender Code: ICB/EPSA6/RDF-R/PH/10/21
Award Status: Amendment
Award Date: 04/11/2022
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
Company Name: | Document No: OF/TM/ HO-16 | ||||||||||
የኢትዮጵያ መድሃኒት አቅራቢ ኤጀንሲ | ||||||||||||
Ethiopian Pharmaceuticals Supply Agency | ||||||||||||
Title: | Effective date : 13/09/2019 | |||||||||||
Official Winner list (Re) | Rev. No.: 0 | Page 1 of 1 | ||||||||||
Tender no: ICB/EPSA6/RDF-R/PH/10/21 | ||||||||||||
Item No. | Description | Unit | Quantity | Winner | Currency | Unit FOB price | Payment Term | Port of shipment | Delivery Time | Remark | ||
Supplier | Country | |||||||||||
37 | Ciprofloxacin – 500mg – Tablet | 10×10 | 295,084 | Pinnacle Life Science Pvt Ltd | India | USD | 1.90 | LC | Mumbai | Within 90 days from LC opening date | ||
80 | Mebendazole – 100mg – Tablet | 40×6 | 67,500 | Bafna Pharmaceuticals Ltd | India | USD | 2.45 | LC | Chennai | Within 60-90 days from LC opening date | ||
99 | Norfloxacin – 400mg – Tablet | 10×10 | 144,587 | Medicamen Biotech Limited | India | USD | 2.70 | LC | Nava Shiva, Mumbai | Within 90 days from LC opening date | ||
OF for Official Winner List, OF/TM/HO-16 0, 13/09/2019 | ||||||||||||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | ||||||||||||
Make sure that this is the correct issue before use |
Reasons for Rejection (Re)
|
Company Name: | Document No: OF/TM/ HO-17 | ||||
የኢትዮጵያ መድሃኒት አቅራቢ ኤጀንሲ | ||||||
Ethiopian Pharmaceuticals Supply Agency | ||||||
Title: | Effective date : 13/09/2019 | |||||
Reasons for Rejection (Re) | Rev. No.: 0 | Page 1 of 1 | ||||
Tender no,: ICB/EPSA6/RDF-R/PH/10/21 | ||||||
Item No | Prdoduct Description | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark | |
37 | Ciprofloxacin – 500mg – Tablet | Scott- edil Pharmacia Ltd | unsuccessful | Not submitted valid EFDA registration certificate | ||
Bafna Pharmaceuticals Ltd. | unsuccessful | Price incompetency | ||||
IDA fundation | unsuccessful | Price incompetency | ||||
FDC Ltd. | unsuccessful | Not submitted valid EFDA registration certificate | ||||
Unique Pharmaceuticals laboratories | unsuccessful | Price incompetency | ||||
Cadila Healthcare ltd. | unsuccessful | Not submitted valid EFDA registration certificate | ||||
CSPC Ouyi Pharmaceutical co.,Ltd. | unsuccessful | Not submitted valid EFDA registration certificate | ||||
Medicamen Biotech Limited | unsuccessful | Not submitted valid EFDA registration certificate | ||||
Medochmie Ltd. | unsuccessful | Price incompetency | ||||
Milan Laboratories india privatre Limited | unsuccessful | Price incompetency | ||||
Sanshang pharmaceticals plc | unsuccessful | Unresponsive quantity | ||||
Pinnacle Life Science Pvt Ltd | Winner | **** | ||||
Reyoung Pharmaceutical Co. Ltd | unsuccessful | Price incompetency | ||||
East African Pharmaceuticals plc | Unwilling to supply | **** | ||||
Brawn Laboratories Ltd. | unsuccessful | Price incompetency | ||||
80 | Mebendazole – 100mg – Tablet | Bafna Pharmaceuticals Ltd. | Winner | **** | ||
Unique Pharmaceuticals laboratories | unsuccessful | Not submitted valid SRAcertificate/GMP waiver certificate | ||||
Scott- edil Pharmacia Ltd | unsuccessful | Not submitted valid SRAcertificate with COPP | ||||
REMEDICA | unsuccessful | Not submitted valid SRAcertificate/GMP waiver certificate | ||||
East African Pharmaceuticals plc | Unwilling to supply | **** | ||||
99 | Norfloxacin – 400mg – Tablet | Scott- edil Pharmacia Ltd | unsuccessful | Not submitted valid EFDA registration certificate | ||
Bafna Pharmaceuticals Ltd. | unsuccessful | Not submitted valid EFDA registration certificate | ||||
Macleods pharmaceticals Ltd. | unsuccessful | Price incompetency | ||||
Medicamen Biotech Limited | Winner | **** | ||||
Sanshang pharmaceticals plc | unsuccessful | Unresponsive quantity | ||||
Pinnacle Life Sciences Pvt Ltd | unsuccessful | Not submitted valid EFDA registration certificate | ||||
East African Pharmaceuticals PLC | Unwilling to supply | **** | ||||
እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Reason for Rejection, OF/TM/HO-17 0, 13/09/2019 | |||||
Make sure that this is the correct issue before use | ||||||